-
Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data
Mar 10, 2025, 14:00 PM -
Cost-effectiveness of Chimeric Antigen Receptor (CAR) T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma (r/r LBCL): A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs
Mar 10, 2025, 14:00 PM -
Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews
Mar 10, 2025, 14:00 PM -
Mapping between the HUI2/HUI3 and the PROPr in the United States
Mar 10, 2025, 14:00 PM -
Economic Impact of Smart Infusion Pump Interoperability: A Cost-Benefit Analysis
Mar 10, 2025, 14:00 PM -
Increase in Healthcare Professionals' Willingness to Counsel HPV Vaccine Hesitant Parents Post-Pandemic: Results from a National Survey
Mar 10, 2025, 14:00 PM -
A Retrospective Analysis of Real-World Data: Assessing and Predicting Cardiovascular Risk Associated with Calcium Channel Blockers in Patients with Hypertension
Mar 10, 2025, 14:00 PM -
The Impact of Glucocorticoid (GC) Dose on Clinical Outcomes in Congenital Adrenal Hyperplasia (CAH): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
30-Day All-Cause Readmission Outcomes Among Kidney Transplant Recipients with vs. without Autosomal Dominant Polycystic Kidney Disease
Mar 10, 2025, 14:00 PM -
National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data
Mar 10, 2025, 14:00 PM -
Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study
Mar 10, 2025, 14:00 PM -
A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices
Mar 10, 2025, 14:00 PM -
Correlation Between Price and Prevalence in Non-Oncology Orphan Products With Recent Trends (2015-2024)
Mar 10, 2025, 14:00 PM -
Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis
Mar 10, 2025, 14:00 PM -
Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy & Testing Policies?
Mar 10, 2025, 14:00 PM -
Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies
Mar 10, 2025, 14:00 PM -
Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of NALIRIFOX As a First-Line Treatment for Metastatic Pancreatic Cancer in Taiwan
Mar 10, 2025, 14:00 PM -
Real-World Overall Survival of Multiple Myeloma Patients in a Colombian HMO During 2015-2023
Mar 10, 2025, 14:00 PM